News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Virani Shafique
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 3,603 shares
@ $9.19, valued at
$33.1k
Sold 18,000 shares
@ $9.25, valued at
$166.5k
Exercised 18,000 options to buy
@ $2.22, valued at
$40k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $14.3, valued at
$286k
Sold 20,000 shares
@ $14.41, valued at
$288.2k
Exercised 20,000 options to buy
@ $2.22, valued at
$44.4k
Exercised 20,000 options to buy
@ $2.22, valued at
$44.4k
|
|
| 07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 25,000 shares
@ $8.58, valued at
$214.5k
Sold 17,865 shares
@ $8.93, valued at
$159.5k
|
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,230 shares
@ $5.6, valued at
$12.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $9.1561, valued at
$91.6k
Exercised 5,000 options to buy
@ $2.22, valued at
$11.1k
|
|
| 12/19/2022 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 10,000 shares
@ $8.8525, valued at
$88.5k
Exercised 5,000 options to buy
@ $2.22, valued at
$11.1k
|
|
| 11/17/2022 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 613 shares
@ $11.86, valued at
$7.3k
Sold 5,059 shares
@ $12.7, valued at
$64.2k
Sold 4,941 shares
@ $11.9153, valued at
$58.9k
Exercised 5,000 options to buy
@ $2.22, valued at
$11.1k
|
|
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 9,600 shares
@ $13.3381, valued at
$128k
Sold 400 shares
@ $13.9725, valued at
$5.6k
Exercised 5,000 options to buy
@ $2.22, valued at
$11.1k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|